Post-abortion long-acting reversible contraception in a sample of Italian women: intrauterine device versus subdermal implant

References

• Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397–404.
   PubMed Web of Science ®Google Scholar
• Madden T, Allsworth JE, Hladky KJ, et al. Intrauterine contraception in Saint Louis: a survey of obstetrician and gynecologist’s knowledge and attitudes. Contraception. 2010;81:112.
   PubMed Web of Science ®Google Scholar
• Yoost J. Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States. Patient Prefer Adherence. 2014;8:947–957.
   PubMed Web of Science ®Google Scholar
• Sonalkar S, Mody S, Gaffield ME. Outreach and integration programs to promote family planning in the extended postpartum period. Int J Gynaecol Obstet. 2014;124:193–197.
   PubMed Web of Science ®Google Scholar
• Rowland S, Gemzell-Danielsson K, for and on behalf of the European Society of Contraception Expert Group on Abortion. Postabortion contraception. Eur J Contraception Reprod Health Care. 2017;22:162–163.
   PubMed Web of Science ®Google Scholar
• Barros Pereira I, Carvalho RM, Graça LM. Intra-abortion contraception with etonogestrel subdermal implant. Eur J Gynecol Reprod Biol. 2015;185:33–35.
   PubMed Web of Science ®Google Scholar
• Mark A, Sonalkar S, Borgatta L. One-year continuation of the etonogestrel contraceptive implant in women with postabortion or interval placement. Contraception. 2013;88:619–623.
   PubMed Web of Science ®Google Scholar
• Madden T, Eisenberg DL, Zhao Q, et al. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement. Obstet Gynecol. 2012;120:1053–1059.
   PubMed Web of Science ®Google Scholar
• Kilander H, Alehagen S, Svedlund L. Likelihood of repeat abortion in a Swedish cohort according to the choice of post-abortion contraception: a longitudinal study. Acta Obstet Gynecol Scand. 2016;95:565–571.
   PubMed Web of Science ®Google Scholar
• Rose SB, Garrett SM, Stanley J. Immediate postabortion initiation of levonorgestrel implants reduces the incidence of births and abortions at 2 years and beyond. Contraception. 2015;92:17–25. Jul;
   PubMed Web of Science ®Google Scholar
• Pohjoranta E, Mentula M, Gissler M, et al. Provision of intrauterine contraception in association with first trimester induced abortion reduces the need of repeat abortion: first-year results of a randomized controlled trial. Hum Reprod. 2015;30:2539–2546.
   PubMed Web of Science ®Google Scholar
• Heikinheimo O, Gissler M, Suhonen S. Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception. 2008;78:149–154.
   PubMed Web of Science ®Google Scholar
• Apter D, Briggs P, Tuppurainen M, et al. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant. Fertil Steril. 2016;106:151–157.
   PubMed Web of Science ®Google Scholar
• Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117:1105–1113.
   PubMed Web of Science ®Google Scholar
• Short M, Dallay D, Omokanye S, et al. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study. Eur J Contracept Reprod Health Care. 2012;17:79–88.
   PubMed Web of Science ®Google Scholar
• Short M, Dallay D, Omokanye S, et al. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study. Eur J Contracept Reprod Health Care. 2014;19:29–38.
   PubMed Web of Science ®Google Scholar
• Driedich JT, Madden T, Zhao Q. Long-term utilization and continuation of intrauterine devices. Am J Obstet Gynecol. 2015;213:822. e1–822. e6.
   Web of Science ®Google Scholar
• Hou MY, Mc Nicholas C, Creinin MD. Combined oral contraceptive treatment for bleeding complaints with the etonogestrel contraceptive implant: a randomised controlled trial. Eur J Contracept Reprod Health Care. 2016;21:361–366.
   PubMed Web of Science ®Google Scholar
• Flamant A, Ouldamer L, Body G, et al. Rates of continuation and satisfaction of immediate intrauterine device insertion following first- or second-trimester surgical abortion: a French prospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2013;169:268–274.
   PubMed Web of Science ®Google Scholar
• Lakha F, Glasier AF. Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception. 2006;74:287–289.
   PubMed Web of Science ®Google Scholar
• Steinauer JE, Upadhyay UD, Sokoloff A, et al. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion. Contraception. 2015;92:553–559.
   PubMed Web of Science ®Google Scholar
• Modesto W, Bahamondes MV, Bahamondes L. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod. 2014;29:1393–1399.
   PubMed Web of Science ®Google Scholar
• Caruso S, Cianci S, Vitale SG, et al. Sexual function and quality of life of women adopting the levonorgestrel-releasing intrauterine system (LNG-IUS 13.5 mg) after abortion for unintended pregnancy. Eur J Contracept Reprod Health Care. 2018;23:24-31.
   PubMed Web of Science ®Google Scholar
• Neri M, Piras B, Paoletti AM, et al. Long-acting reversible contraception (LARC) with the intrauterine system with levonorgestrel (6 mcg/d): observational study on the acceptability, quality of life, and sexuality in Italian women. Gynecol Endocrinol. 2017;19:1–4.
   Google Scholar
• World Health Organization. . Safe abortion: technical and policy guidance for health systems. 2nd edition. Geneva: World Health Organization; 2012.
   Google Scholar
• Fraser I, Critchley H, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29:383–390.
   PubMed Web of Science ®Google Scholar
• Lauria L, Donati S, Spinelli A, et al. The effect of contraceptive counselling in the pre and post-natal period on contraceptive use at three months after delivery among Italian and immigrant women. Ann Ist Super Sanita. 2014;50:54–61.
   PubMed Web of Science ®Google Scholar
• Gemzell-Danielsson K, Kopp HK. Post abortion contraception. Womens Health (Lond). 2015;11:779–784.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Bateson D, Knox S, et al. Do women and providers value the same features of contraceptive products? Results of a best-worst stated preference experiment. Eur J Contracept Reprod Health Care. 2013;18:181–190.
   PubMed Web of Science ®Google Scholar
• Sonalkar S, Hou MY, Borgatta L. Administration of the etonogestrel contraceptive implant on the day of mifepristone for medical abortion: a pilot study. Contraception. 2013;88:671–673.
   PubMed Web of Science ®Google Scholar
• Dickerson LM, Diaz VA, Jordon J. Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med. 2013;45:701–707.
   PubMed Web of Science ®Google Scholar
• Grunloh DS, Casner T, Secura GM. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol. 2013;122:1214–1221.
   PubMed Web of Science ®Google Scholar
• Menstrual bleeding changes with different contraceptive methods. Contracept Rep. 1997;8:1–2. PMID:12293020.
   Google Scholar